Ionis Pharmaceuticals, Inc. — Revenue by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/12bfec10-1d80-4524-85eb-e5a0180fcfd7/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $943.7M | 2025-01-01 – 2025-12-31 | evidence 0000874015-26-000115 |
| FY 2024 | $705.1M | 2024-01-01 – 2024-12-31 | evidence 0000874015-25-000089 |
| FY 2023 | $787.6M | 2023-01-01 – 2023-12-31 | evidence 0000874015-24-000116 |
| FY 2022 | $587.4M | 2022-01-01 – 2022-12-31 | evidence 0000874015-23-000105 |
| FY 2021 | $810.5M | 2021-01-01 – 2021-12-31 | evidence 0000874015-22-000079 |
| FY 2020 | $729.3M | 2020-01-01 – 2020-12-31 | evidence 0000874015-21-000056 |
| FY 2019 | $1.1B | 2019-01-01 – 2019-12-31 | evidence 0001140361-20-004500 |
| FY 2018 | $599.7M | 2018-01-01 – 2018-12-31 | evidence 0000874015-19-000045 |
| FY 2017 | $514.2M | 2017-01-01 – 2017-12-31 | evidence 0000874015-19-000045 |
| FY 2016 | $372.8M | 2016-01-01 – 2016-12-31 | evidence 0000874015-19-000045 |
| FY 2015 | $283.7M | 2015-01-01 – 2015-12-31 | evidence 0000874015-16-000112 |
| FY 2014 | $214.2M | 2014-01-01 – 2014-12-31 | evidence 0001140361-15-009498 |
| FY 2013 | $147.3M | 2013-01-01 – 2013-12-31 | evidence 0001104659-14-015019 |
| FY 2012 | $102.0M | 2012-01-01 – 2012-12-31 | evidence 0001104659-13-016208 |
| FY 2011 | $99.1M | 2011-01-01 – 2011-12-31 | evidence 0001104659-12-014567 |
| FY 2010 | $108.5M | 2010-01-01 – 2010-12-31 | evidence 0001104659-11-011094 |
| FY 2009 | $121.6M | 2009-01-01 – 2009-12-31 | evidence 0001104659-11-011094 |
| FY 2008 | $107.2M | 2008-01-01 – 2008-12-31 | evidence 0001104659-11-011094 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Ionis Pharmaceuticals, Inc. — all facts · Net Income · Operating Income